PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 123 filers reported holding PTC THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,148,636 | +6.8% | 135,665 | +1.6% | 0.00% | 0.0% |
| Q1 2024 | $3,885,406 | +5.6% | 133,565 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $3,681,051 | +11.9% | 133,565 | -9.0% | 0.00% | 0.0% |
| Q3 2023 | $3,289,004 | -44.1% | 146,765 | +1.5% | 0.00% | -25.0% |
| Q2 2023 | $5,883,526 | -13.0% | 144,665 | +3.7% | 0.00% | -20.0% |
| Q1 2023 | $6,760,529 | +13.9% | 139,565 | -10.2% | 0.01% | +25.0% |
| Q4 2022 | $5,934,099 | -22.4% | 155,465 | +2.1% | 0.00% | -20.0% |
| Q3 2022 | $7,644,000 | +26.1% | 152,265 | +0.7% | 0.01% | +25.0% |
| Q2 2022 | $6,060,000 | +7.9% | 151,265 | +0.5% | 0.00% | +33.3% |
| Q1 2022 | $5,614,000 | +0.6% | 150,465 | +7.3% | 0.00% | 0.0% |
| Q4 2021 | $5,583,000 | +7.0% | 140,165 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,216,000 | -11.5% | 140,165 | +0.5% | 0.00% | -25.0% |
| Q2 2021 | $5,895,000 | -11.2% | 139,465 | -0.6% | 0.00% | 0.0% |
| Q1 2021 | $6,642,000 | -21.0% | 140,265 | +1.8% | 0.00% | -33.3% |
| Q4 2020 | $8,408,000 | +40.2% | 137,765 | +7.4% | 0.01% | +20.0% |
| Q3 2020 | $5,996,000 | -4.6% | 128,265 | +3.6% | 0.01% | 0.0% |
| Q2 2020 | $6,285,000 | +31.0% | 123,865 | +15.2% | 0.01% | 0.0% |
| Q1 2020 | $4,798,000 | -1.6% | 107,565 | +5.9% | 0.01% | 0.0% |
| Q4 2019 | $4,878,000 | +45.6% | 101,565 | +2.5% | 0.01% | +25.0% |
| Q3 2019 | $3,350,000 | -22.3% | 99,065 | +3.4% | 0.00% | -20.0% |
| Q2 2019 | $4,309,000 | +22.1% | 95,765 | +2.1% | 0.01% | +25.0% |
| Q1 2019 | $3,529,000 | +36.3% | 93,765 | +24.2% | 0.00% | +33.3% |
| Q4 2018 | $2,590,000 | -20.0% | 75,465 | +9.6% | 0.00% | -25.0% |
| Q3 2018 | $3,237,000 | +56.2% | 68,865 | +12.0% | 0.00% | +100.0% |
| Q2 2018 | $2,073,000 | +4.1% | 61,465 | -16.4% | 0.00% | 0.0% |
| Q1 2018 | $1,991,000 | +82.0% | 73,565 | +12.2% | 0.00% | +100.0% |
| Q4 2017 | $1,094,000 | -16.6% | 65,565 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,312,000 | +26.5% | 65,565 | +15.9% | 0.00% | 0.0% |
| Q2 2017 | $1,037,000 | +110.3% | 56,565 | +13.0% | 0.00% | 0.0% |
| Q1 2017 | $493,000 | -9.7% | 50,065 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $546,000 | -22.1% | 50,065 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $701,000 | +99.7% | 50,065 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $351,000 | +19.8% | 50,065 | +6.1% | 0.00% | 0.0% |
| Q1 2016 | $293,000 | -76.0% | 47,165 | +25.2% | 0.00% | -66.7% |
| Q4 2015 | $1,220,000 | +21.3% | 37,665 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,006,000 | -36.2% | 37,665 | +15.0% | 0.00% | -25.0% |
| Q2 2015 | $1,577,000 | +9.8% | 32,765 | +38.8% | 0.00% | 0.0% |
| Q1 2015 | $1,436,000 | +20.1% | 23,600 | +2.2% | 0.00% | 0.0% |
| Q4 2014 | $1,196,000 | +37.2% | 23,100 | +16.5% | 0.00% | +33.3% |
| Q3 2014 | $872,000 | +68.3% | 19,820 | 0.0% | 0.00% | +50.0% |
| Q2 2014 | $518,000 | 0.0% | 19,820 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $518,000 | +407.8% | 19,820 | +230.3% | 0.00% | – |
| Q4 2013 | $102,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
| Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
| RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
| GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
| Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
| SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
| SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
| Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
| Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |